πŸ”΄

URGENT ACTION REQUIRED

E. coli >100k CFU confirmed β€” IV Ceftriaxone 1g not ordered. Call HCP now.

View Actions β†’
CJMM/ADPIE 8 Phases In Progress Full Code

UTI with Suspected Urosepsis

68F Β· Inpatient Med-Surg Β· COPD Γ— 6 years Β· Updated April 15, 2026

SpOβ‚‚ Now
92%
2L NC Β· COPD target βœ“
Antibiotic
🚫
Not ordered β€” overdue
  • Assess
  • Recognize
  • Analyze
  • Prioritize
  • Solutions
  • Plan
  • Implement
  • Evaluate
92%
SpOβ‚‚
2L NC Β· COPD target
βœ… Met
<2.0
Lactate
mmol/L Β· reassuring
βœ… Low risk
🚫
Antibiotic
IV Ceftriaxone
πŸ”΄ Overdue
↑
AMS
More alert post-Oβ‚‚
⚠️ Improving
5
Diagnoses
2 critical Β· 1 met
View all β†’

Phase Status β€” Click to Drill In

πŸ“Š Living Care Plan Summary

Updated: Apr 15, 2026

Active NANDA-I Diagnoses

# Diagnosis Code Outcome Status Intervention
1 Risk for Sepsis 00275 ⚠️ Partially Met
Lactate <2.0, but antibiotic not started
πŸ”΄ Overdue
2 Impaired Urinary Elimination 00016 πŸ”΄ Not Met
Pathogen confirmed, treatment not initiated
πŸ”΄ Pending order
3 Impaired Gas Exchange 00030 βœ… Met
SpOβ‚‚ 92% on 2L NC β€” COPD target 88–92%
βœ… Oβ‚‚ in place
4 Acute Confusion 00128 βœ… Progressing
More alert and responsive
βœ… Oβ‚‚ + reorientation
5 Acute Pain 00132 ❌ Not Met
Pain unchanged, analgesic not given
⏳ Pending order

Intervention Tracker

InterventionStatusNotes
Supplemental Oβ‚‚ (2L NC)βœ… DoneSpOβ‚‚ 92% β€” COPD target achieved
Fall precautionsβœ… DoneBed lowest, rails up, call light in reach
Continuous SpOβ‚‚ monitoringβœ… DonePer unit protocol
Blood cultures Γ— 2βœ… DrawnResults pending
CBC / BMP / Lactateβœ… DrawnLactate <2.0 confirmed; others pending
UA + reflex cultureβœ… Resulted+nitrites, +leukocyte esterase, E. coli >100k CFU β€” culture/sensitivity pending (24–48h)
Reorientation q1hβœ… In progressPatient more alert β€” active engagement feasible
IV Antibiotics (Ceftriaxone 1g IV)πŸ”΄ OverdueE. coli confirmed; no order yet β€” escalate to HCP immediately
IV access⚠️ UnknownNot documented
Analgesic (acetaminophen)⏳ PendingInclude in HCP call
Medication reconciliation❌ Not completeCritical gap β€” meds affect antibiotic safety

Outstanding Actions

  • πŸ”΄ Urgent Call HCP with UA result β€” request IV Ceftriaxone 1g q24h + analgesic order. E. coli >100k confirmed β€” antibiotic is overdue.
  • πŸ”΄ Urgent Confirm IV access is established. Required before antibiotic administration.
  • ⚠️ Needed Medication reconciliation β€” full med list. Affects antibiotic safety, drug interactions, HR interpretation.
  • ⚠️ Needed Formal orientation assessment. Patient now alert enough to assess.
  • πŸ“‹ Pending Serial lactate if symptoms persist or worsen after antibiotic initiation.
  • πŸ“‹ Pending Patient/family teaching when patient fully alert.

Current Loop Indicators

TriggerRe-EnterStatus
βœ… UA resulted β€” E. coli >100k CFU Phase 3 β€” Analyze Cues βœ… Complete
Culture/sensitivity results (24–48h) Phase 3 β€” Analyze Cues (antibiotic de-escalation) ⏳ Awaiting
CBC / BMP / blood cultures result Phase 3 β€” Analyze Cues (organ dysfunction) ⏳ Awaiting
Antibiotic initiated Phase 7 + Phase 8 (re-evaluate 4–6h post) ⏳ Awaiting order
AMS resolves or worsens Phase 4 β€” Prioritize Hypotheses ⏳ Monitoring
1
Assess ADPIE: Assessment CJMM: Data Gathering

1.1 Subjective Data

CategoryFinding
Chief complaintDysuria (no hematuria), urinary frequency, urgency, suprapubic pain
Medical historyCOPD Γ— 6 years
Current medicationsUnknown β€” medication reconciliation not yet completed
AllergiesUnknown
Patient concernsUnable to fully assess β€” patient lethargic

1.2 Objective Data

FindingValueReference
Temperature98.3Β°FNormal (afebrile)
Heart Rate68 bpmWithin normal limits
Blood Pressure138/82 mmHgElevated β€” Stage 1 HTN
Respiratory Rate19 breaths/minWithin normal limits
SpOβ‚‚88% on room air⚠️ Critical in context of COPD
Mental statusLethargic β€” drowsy but arousableChange from baseline
CVA tendernessAbsentNo costovertebral angle involvement
Focal tendernessAbsentNo rebound, guarding

1.3 Diagnostic Tests

  • βœ… Resulted UA + reflex culture β€” +nitrites, +leukocyte esterase, E. coli >100,000 CFU/mL β€” culture/sensitivity pending (24–48h)
  • ⏳ Pending Blood cultures Γ— 2 β€” drawn
  • ⏳ Pending CBC β€” drawn
  • ⏳ Pending BMP β€” drawn
  • βœ… Partial Lactate β€” confirmed <2.0; serial monitoring ongoing

1.4 Baseline Documentation Summary

Afebrile 68F on med-surg with classic lower UTI triad (dysuria, frequency, urgency, suprapubic pain), presenting atypically with new-onset lethargy and SpOβ‚‚ 88% on room air. COPD adds respiratory vulnerability. Medications unknown β€” critical gap for clinical interpretation.

2
Recognize Cues ADPIE: Assessment+ CJMM: Step 1

2.1 Cue Sorting

CueRelevantIrrelevantRationale
Dysuria, frequency, urgency, suprapubic painβœ…Classic lower UTI triad
No hematuriaβœ…Absent β€” does not redirect diagnosis
No CVA tendernessβœ…Pyelonephritis less supported without this
SpOβ‚‚ 88% on RAβœ…Critical β€” below safe threshold for COPD patient
New-onset lethargy (change from baseline)βœ…AMS = systemic involvement or sepsis signal
HR 68 (normal)βœ…May be masked by beta-blocker β€” cannot dismiss
Temp 98.3Β°F (afebrile)βœ…Classic atypical sepsis in older adults
BP 138/82βœ…Elevated; watch MAP drop = sepsis signal
COPD Γ— 6 yearsβœ…Alters SpOβ‚‚ targets; increases hypoxia risk

2.2 Abnormal Findings

FindingWhy AbnormalUrgency
SpOβ‚‚ 88% on RABelow safe threshold; COPD target is 88–92% on Oβ‚‚πŸ”΄ Critical
New-onset lethargyAMS in older adult = systemic deterioration signalπŸ”΄ Critical
Afebrile despite infectionOlder adults may not mount fever; masks sepsis⚠️ Deceptive
HR 68 with possible infectionMay be pharmacologically masked (beta-blocker unknown)⚠️ Deceptive
BP 138/82Elevated; watch for downward drift (MAP <65)πŸ“‹ Monitor

2.3 Urgent / Time-Sensitive Cues

2.4 SBAR β€” HCP Notification (Phase 2 Checkpoint)

S: I'm calling about Mrs. [Patient], 68F on 4 West with dysuria and urinary symptoms.

B: PMH COPD Γ— 6 years. Admitted with urinary frequency, urgency, dysuria, suprapubic pain. No hematuria. Afebrile at 98.3Β°F. Meds unknown.

A: SpOβ‚‚ 88% on room air β€” new. Mental status lethargic and drowsy but arousable β€” change from baseline. HR 68, BP 138/82, RR 19. UA and cultures sent. No Oβ‚‚ order currently in place.

R: Requesting order for supplemental Oβ‚‚, sepsis workup (blood cultures, CBC, BMP, lactate), and antibiotic initiation. Requesting q1h VS order. Will you be coming to assess?

3
Analyze Cues ADPIE: Diagnosis (input) CJMM: Step 2 UA Updated

3.1 Cue Clusters

ClusterCuesImplication
Lower UTIDysuria, frequency, urgency, suprapubic pain, no CVA tendernessBladder-localized infection; possible ascending
Urosepsis / Systemic ResponseNew AMS, afebrile, SpOβ‚‚ 88%, HR 68 (possibly masked)Infection may have crossed into systemic response
Respiratory CompromiseSpOβ‚‚ 88% on RA, COPD Γ— 6yr, RR 19Baseline impaired gas exchange worsened by infection
Atypical Sepsis (older adult)No fever, no tachycardia, AMS changeBlunted inflammatory response; classic masking pattern

3.2 Pathophysiological Explanation

  • UTI β†’ Urosepsis pathway: E. coli (confirmed gram-negative rod) enters bloodstream via urinary tract β†’ endotoxin release β†’ SIRS β†’ sepsis β†’ organ dysfunction if untreated. Gram-negative bacteremia is the most common pathogen in urosepsis.
  • Blunted fever response: Older adults have impaired thermoregulation; afebrile presentation does NOT rule out serious infection β€” confirmed here with active E. coli bacteriuria.
  • Medication masking: Unknown medications β€” if patient takes beta-blockers, HR 68 may mask expected tachycardia of sepsis.
  • Hypoxia + COPD + Infection: V/Q mismatch worsened by systemic inflammation; SpOβ‚‚ 88% on RA was clinically significant β€” now improved to 92% on 2L NC.
  • AMS + Hypoxia correlation: AMS improving with Oβ‚‚ correction β€” lethargy was likely primarily hypoxia-driven, though sepsis-mediated delirium cannot be fully excluded until culture results return.
  • Antibiotic pharmacology β€” E. coli specific: Nitrofurantoin EXCLUDED (inadequate serum levels for systemic infection); fluoroquinolone and TMP-SMX resistance must be confirmed via sensitivity before use; IV ceftriaxone is appropriate empirical choice.

3.3 Cross-System Relationships

Lower UTI (bladder)
    β†’ Ascending infection risk (kidneys)
    β†’ Bacteremia risk (bloodstream)
    β†’ SIRS/Sepsis β†’ AMS + hemodynamic instability
    β†’ Compounded by COPD β†’ SpOβ‚‚ 88% worsens under systemic stress
    β†’ Medications unknown β†’ masking HR response

3.4 Links to Clinical Conditions

ConditionSupporting CuesAgainst
UrosepsisE. coli >100k confirmed AMS (improving), afebrile with infection, age, SpOβ‚‚ 88%Lactate <2.0, HR 68, no hypotension; AMS improving
Delirium (hypoxia-driven)AMS change from baseline; improving with Oβ‚‚Less likely sepsis-mediated given AMS response to Oβ‚‚
PyelonephritisE. coli UTI with urosepsis risk, AMSNo CVA tenderness; not yet proven ascending
COPD ExacerbationSpOβ‚‚ 88% on admission, COPD historySpOβ‚‚ improved to 92% on 2L NC; no wheezing documented
Uncomplicated CystitisGU triad, E. coli confirmedDoes NOT explain AMS or SpOβ‚‚ drop β€” excluded as sole diagnosis
4
Prioritize Hypotheses ADPIE: Diagnosis (output) CJMM: Step 3

4.1 Differential Diagnoses

RankHypothesisUrgencyLikelihoodRisk if Missed
1Urosepsis / Early SepsisπŸ”΄ CriticalHighDeath, organ failure
2Delirium (hypoxia-driven or sepsis-mediated)πŸ”΄ UrgentHighFalls, aspiration, harm
3Impaired Gas Exchange (COPD + infection)πŸ”΄ UrgentHighRespiratory failure
4Pyelonephritis⚠️ SeriousModerateAscending sepsis if untreated
5Uncomplicated UTIπŸ“‹ ModerateLow (alone)Inadequate β€” does not explain full picture
6Hypertensive episodeπŸ“‹ MonitorLowDoes not explain AMS or SpOβ‚‚

4.2 Priority Nursing Diagnoses (NANDA-I)

#NANDA-I DiagnosisCodeDefining CharacteristicsRelated Factors
1 Risk for Sepsis 00275 AMS (improving), afebrile with confirmed E. coli bacteriuria, SpOβ‚‚ 88% on admission Confirmed E. coli UTI, age, COPD, immunosenescence β€” antibiotic not yet started
2 Impaired Urinary Elimination 00016 Frequency, urgency, dysuria; UA confirms E. coli >100k CFU Confirmed bacterial UTI β€” E. coli; antibiotic initiation outstanding
3 Impaired Gas Exchange 00030 SpOβ‚‚ 88% on RA (improved to 92% on 2L NC) COPD Γ— 6yr, systemic infection, V/Q mismatch
4 Acute Confusion 00128 Lethargy improving; was drowsy but arousable Hypoxia (primary driver β€” AMS responding to Oβ‚‚), infection, age
5 Acute Pain 00132 Dysuria, suprapubic pain, urinary urgency β€” unchanged UTI bladder inflammation; analgesic not yet administered

4.3 Ruled-Out Hypotheses

  • Uncomplicated cystitis alone: Cannot explain SpOβ‚‚ 88% or new AMS β€” rejected as sole diagnosis.
  • Hypertensive crisis: BP 138/82 is elevated but not crisis level; does not drive clinical picture.
5
Generate Solutions ADPIE: Planning (outcomes) CJMM: Step 4a

5.1 SMART Outcome Statements

DiagnosisSMART OutcomeTimeframe
Risk for SepsisLactate <2.0 (confirmed); no hemodynamic deterioration; antibiotics initiated within 1h of UA resultImmediate
Impaired Urinary Eliminationβœ… Pathogen confirmed (E. coli >100k CFU); antibiotic initiated within 1h of result; decreased dysuria within 24hNOW
Impaired Gas ExchangeSpOβ‚‚ β‰₯88% on ≀4L NC (COPD target); βœ… 92% on 2L NC achievedβœ… Met β€” maintain
Acute ConfusionPatient oriented to name/place/time; arouses to voice4 hours
Acute PainPatient rates pain ≀3/10 after analgesic1h post-analgesic

5.2 Intervention Options

DiagnosisOptions
Risk for SepsisπŸ”΄ Escalate to HCP now with UA results β€” antibiotic order outstanding; q1h VS ongoing; sepsis protocol if lactate β‰₯2.0; IV access; fluid challenge if MAP <65
Impaired Urinary EliminationπŸ”΄ Antibiotic IMMEDIATELY β€” E. coli confirmed; IV Ceftriaxone 1g q24h preferred; await sensitivity before stepping to oral; encourage oral fluids if tolerated
Impaired Gas Exchangeβœ… Oβ‚‚ 2L NC in place; SpOβ‚‚ 92% (COPD target met); maintain; reassess with serial monitoring
Acute PainNon-opioid analgesic (acetaminophen); phenazopyridine if ordered (check BMP for renal function first); reassess 1h post
Acute Confusionβœ… Oβ‚‚ in place (primary intervention); reorientation q1h; patient now more alert β€” engage actively; low-stimulation environment

Antibiotic Exclusion Table

AntibioticStatusReason
Nitrofurantoin❌ ExcludedInadequate serum/blood levels β€” not appropriate when systemic infection (urosepsis) is possible
TMP-SMX⚠️ HoldE. coli resistance 15–25% regionally; await sensitivity
Fluoroquinolone⚠️ HoldResistance increasing; await sensitivity; avoid if SSRI/QTc concerns (meds unknown)
IV Ceftriaxoneβœ… First-lineGram-negative coverage; adequate serum levels; safe pending allergy confirmation
CarbapenemReserveFor ESBL or resistant E. coli β€” await sensitivity

5.3 Benefits and Potential Harms

InterventionBenefitRisk
Supplemental Oβ‚‚Corrects hypoxia, may resolve AMSOver-oxygenation β†’ hypercapnia in COPD; target 88–92% only
AntibioticsTreats infection, prevents sepsis progressionAllergy unknown; drug-drug interactions unknown; culture before start
IV FluidsSupports hemodynamics if sepsisFluid overload risk in COPD; use conservative strategy
PhenazopyridineUrinary analgesicContraindicated if renal impairment (BMP pending); stains urine orange

5.4 Evidence Base

  • πŸ“– Sepsis-3 / SSC 2021: lactate β‰₯2.0, blood cultures before antibiotics, 1-hour bundle; gram-negative bacteremia = high urosepsis risk
  • πŸ“– IDSA UTI Guidelines 2022: IV ceftriaxone preferred empiric for complicated UTI or urosepsis risk; nitrofurantoin NOT for systemic infection
  • πŸ“– BTS / GOLD: SpOβ‚‚ target 88–92% for COPD on supplemental Oβ‚‚ β€” achieved
  • πŸ“– NICE Delirium: treat root cause first; minimize antipsychotics; reorientation
  • πŸ“– ASHP/IDSA Antibiogram Guidance: local E. coli resistance patterns guide TMP-SMX and fluoroquinolone use
6
Plan ADPIE: Planning (docs) CJMM: Step 4b

6.1 Sequenced Interventions

#InterventionPriorityByWhen
1Apply Oβ‚‚ 2L NC; target SpOβ‚‚ 88–92%πŸ”΄RNNow
2Continuous SpOβ‚‚ monitoring; reassess q15 minπŸ”΄RNOngoing
3Establish IV access (18g or larger)πŸ”΄RNNow
4Obtain blood cultures Γ— 2 (before antibiotics)πŸ”΄RNBefore abx
5Draw CBC, BMP, lactateπŸ”΄RNNow
6Implement fall precautions; bed lowest; call light in reachπŸ”΄RN + UAPNow
7Reorientation: name, place, time, nurse name; calm tone⚠️RN + UAPq1h
8q1h vital signs including SpOβ‚‚ and neuro check⚠️RN + UAPOngoing
9Initiate antibiotics when ordered⚠️RNPer HCP order
10Administer analgesic per order⚠️RNPer order
11Conservative IV fluids if MAP <65 or lactate β‰₯2.0⚠️RNPer HCP
12Medication reconciliation β€” obtain full med listπŸ“‹RNThis shift

6.2 Delegation

TaskRNUAP
Oβ‚‚ applicationβœ… InitiatesMonitors and reports
Fall precautionsβœ… Ordersβœ… Implements
Vital signsβœ… Interpretsβœ… Obtains and documents
Reorientationβœ… Assesses responseβœ… Performs
Blood drawsβœ…β€”
Medication administrationβœ…β€”

6.3 Patient/Family Teaching

6.4 Interdisciplinary Communication (SBAR)

S: Calling to request orders for 68F with UTI and concerning new findings.

B: COPD Γ— 6yr. SpOβ‚‚ 88% RA, new lethargy (change from baseline), blood cultures drawn, UA pending at time of initial call.

A: SpOβ‚‚ improving concern for urosepsis. No current Oβ‚‚ order, no antibiotics ordered.

R: Requesting: (1) Oβ‚‚ order 2L NC target SpOβ‚‚ 88–92%, (2) empiric antibiotics per protocol, (3) q1h VS order, (4) sepsis protocol if lactate β‰₯2.0.

7
Implement / Take Action ADPIE: Implementation CJMM: Step 5 πŸ”΄ Abx Gap

7.1 Interventions Executed

InterventionStatusNotes
Fall precautionsβœ… DoneBed lowest, call light in reach, rails up
Oβ‚‚ supplemental⏳ Pending HCPNot yet applied at time of initial documentation
Continuous SpOβ‚‚ monitoringβœ… In progressPer unit protocol
IV access⚠️ UnknownNot documented
Blood culturesβœ… DrawnPending results
CBC / BMP / Lactateβœ… DrawnLactate <2.0 confirmed; others pending
Reorientationβœ… In progressPatient lethargic initially; now more alert
AntibioticsπŸ”΄ CRITICAL GAPE. coli confirmed β€” escalate immediately; IV Ceftriaxone 1g recommended
Analgesic⏳ Pending orderNot yet administered
Medication reconciliation❌ Not completeCritical outstanding task

7.2 Monitoring Parameters

ParameterEscalation ThresholdAction
SpOβ‚‚<88% despite Oβ‚‚Increase Oβ‚‚, notify HCP immediately
MAP<65 mmHgNotify HCP; fluid challenge per order
RR>22 breaths/minNotify HCP; reassess respiratory status
Lactateβ‰₯2.0 mmol/LActivate sepsis protocol per HCP
Mental statusWorsening β€” harder to arouseNotify HCP immediately; SBAR

7.3 Real-Time Adaptations

None documented at time of implementation.

8
Evaluate Outcomes ADPIE: Evaluation CJMM: Step 6 ~1h post-intervention

8.1 Actual vs. Expected Outcomes

#DiagnosisTargetCurrent StatusMet?
1Risk for Sepsis Lactate <2.0, hemodynamics stable; abx within 1h of UA Lactate <2.0 confirmed; HR/BP stable; antibiotic NOT initiated despite confirmed E. coli ⚠️ Partial
2Impaired Urinary Elimination Antibiotic within 1h of UA result; decreased dysuria within 24h E. coli >100k confirmed; antibiotic not yet ordered πŸ”΄ Not Met
3Impaired Gas Exchange SpOβ‚‚ β‰₯88% on Oβ‚‚ (COPD target) SpOβ‚‚ 92% on 2L NC β€” COPD target achieved βœ… Met
4Acute Confusion Oriented to name/place/time by 4h More alert and responsive β€” improving βœ… Progressing
5Acute Pain Pain ≀3/10 after analgesic Pain unchanged β€” analgesic not yet administered ❌ Not Met

8.2 Trending Data Since Intervention

CueAt AssessmentNowTrend
SpOβ‚‚88% on RA92% on 2L NC↑ COPD target achieved
Mental statusLethargic; drowsy but arousableMore alert and responsive↑ Improving
LactatePending<2.0βœ… Septic shock pathway less likely
HR68No new data→ Stable; monitor
BP138/82No new data→ Stable
Dysuria / urinary sxFrequency, urgency, suprapubic painUnchanged→ Antibiotics not initiated
UAPending+nitrites, +leukocyte esterase, E. coli >100k CFUπŸ”΄ Treatment required now
CBC / BMP / Blood culturesPendingStill pending⚠️ Awaiting

8.3 Contributing Factors

UA Resulted β€” E. coli >100,000 CFU/mL β€” Critical update

  • Confirms E. coli (gram-negative rod) β€” most common urosepsis pathogen
  • +nitrites (gram-neg bacteriuria) + +leukocyte esterase (WBC in urine)
  • Antibiotic initiation is NOW indicated β€” 1-hour bundle clock resets from this result
  • HCP escalation required immediately with UA result in hand
  • Culture/sensitivity pending (24–48h) β€” empiric IV ceftriaxone appropriate; de-escalate per sensitivity

Lactate <2.0 β€” Maintained significance

  • Sepsis-3: lactate β‰₯2.0 required for sepsis classification; <2.0 reduces septic shock risk
  • Does NOT rule out infection β€” E. coli is confirmed; antibiotics are no longer optional
  • Serial lactate recommended β€” gram-negative bacteremia risk; lactate can rise if treatment delayed

SpOβ‚‚ 92% on 2L NC β€” Target achieved (COPD-adjusted)

  • BTS/GOLD: 88–92% is appropriate for COPD; do NOT escalate to 94–98%
  • Do NOT increase Oβ‚‚ delivery without HCP order β€” hypercapnic drive risk

AMS improving β€” Significant correlation

  • AMS improvement after Oβ‚‚ suggests lethargy was primarily hypoxia-driven
  • Acute Confusion may be secondary to Impaired Gas Exchange β€” continue monitoring for full reorientation

8.4 Intervention Modifications

DiagnosisDecisionRationale
Risk for SepsisπŸ”΄ Re-escalateE. coli confirmed; antibiotic is overdue; gram-negative bacteriuria without treatment = active urosepsis risk
Impaired Urinary EliminationπŸ”΄ Escalate immediatelyE. coli >100k confirmed; every hour of delay increases sepsis risk
Impaired Gas Exchangeβœ… ContinueSpOβ‚‚ 92% on 2L NC; target 88–92% maintained; do not over-oxygenate
Acute Confusionβœ… ContinuePatient more alert; escalate reorientation; monitor for full return to baseline
Acute Pain⚠️ EscalatePain unchanged; patient alert enough to rate; include analgesic in HCP call

SBAR Update β€” Call with UA Result

S: Calling to report critical UA result for 68F with UTI/urosepsis risk on 4 West.

B: COPD Γ— 6yr. SpOβ‚‚ now 92% on 2L NC. Lactate <2.0. AMS improving. Blood cultures and CBC/BMP pending.

A: UA resulted: +nitrites, +leukocyte esterase, E. coli >100,000 CFU/mL. No antibiotic has been ordered or started. Active urosepsis risk with confirmed gram-negative bacteriuria.

R: Requesting: (1) IV Ceftriaxone 1g IV q24h, (2) analgesic order (acetaminophen), (3) confirm culture/sensitivity will guide de-escalation. Will you be updating orders now?

8.5 New Cues / Loop Indicator

TriggerRe-Enter Phase
βœ… UA resulted β€” E. coli >100kβœ… Re-entered Phase 3 (complete)
Culture/sensitivity (24–48h)Phase 3 β€” de-escalate or adjust antibiotic
CBC / BMP / blood cultures resultPhase 3 β€” organ dysfunction, bacteremia
Antibiotic initiatedPhase 7 + Phase 8 (re-evaluate 4–6h post)
AMS resolves or worsensPhase 4 β€” Prioritize Hypotheses
Serial lactate β€” if rising despite treatmentPhase 4 β€” escalate sepsis hypothesis

8.6 Evaluation Documentation

πŸ”΄ Outstanding Actions Requiring Follow-Up

  • URGENT: Contact HCP NOW with UA result β€” E. coli >100k CFU confirmed; request IV Ceftriaxone 1g q24h + analgesic order.
  • Antibiotic initiation immediately upon order receipt.
  • Analgesic (acetaminophen) order β€” include in same HCP call.
  • Medication reconciliation β€” full med list (meds still unknown; affects antibiotic safety and drug interactions).
  • Re-evaluate all outcomes 4–6 hours after antibiotic initiation.
  • Serial lactate β€” repeat if symptoms persist or worsen despite antibiotic initiation.
  • Re-enter Phase 3 when culture/sensitivity returns (24–48h) β€” guide antibiotic de-escalation.
  • Re-enter Phase 3 when CBC, BMP, blood cultures result β€” may reveal organ dysfunction or bacteremia.
  • Formal orientation assessment (patient now more alert).
  • Patient/family teaching when patient fully alert.

Document generated using the CJMM/ADPIE Combined 8-Phase Clinical Judgment Model